Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability